Our observations reveal reduced glucose uptake and lactate production within prostate tumor tissues under XHP intervention, accompanied by a decline in the expression of glycolytic enzymes (GLUT1, HK2, and PKM2). The gene discussed is SLC2A1; the disease is prostate neoplasm.